Dar Zavain

CIK 00018520751 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001852075

Recent Transactions

27 trades

Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-07-01+5,109→ 240,764 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-06-17+88,424→ 235,655 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-04-01+4,902→ 147,231 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-02+3,571→ 142,329 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-01+2,941→ 138,758 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-07-01+2,924→ 135,817 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-06-18+22,016→ 132,893 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2025-06-18+44,031→ 44,031 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-04-01+2,745→ 110,877 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-01-02+1,907→ 108,132 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-01+2,229→ 106,225 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-01+1,843→ 103,996 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-03+13,097→ 102,153 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-06-03+26,193→ 26,193 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-01+1,467→ 89,056 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-02+1,393→ 55,216 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-12-14$9.00/sh−20,141→ 53,823 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-02+1,920→ 73,964 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-03+1,863→ 72,044 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-16+12,612→ 70,181 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-06-16+25,224→ 25,224 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-04-03+1,996→ 57,569 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-04-03+1,996→ 22,561 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-07-08+2,420→ 20,565 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-06-14+18,145→ 18,145 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (right to buy)
2022-06-14+36,290→ 36,290 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A common stock
2021-12-07+3,599→ 3,599 total

Companies

RECURSION PHARMACEUTICALS, INC.
Director
$RXRX

Recent Filings

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov